Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Belsomra
Belsomra
Idorsia scores FDA go-ahead for insomnia drug Quviviq to rival Merck’s Belsomra, Eisai’s Dayvigo
Fierce Pharma
Mon, 01/10/22 - 11:37 pm
Idorsia
Quviviq
insomnia
FDA
Merck
Belsomra
Chasing Merck, Eisai launches insomnia drug Dayvigo in Japan
Pharmaforum
Tue, 07/7/20 - 10:40 am
Eisai
Dayvigo
Japan
insomnia
Merck
Belsomra
Merck's Insomnia Drug Approved for Alzheimer's Patients
Motley Fool
Mon, 02/3/20 - 11:48 pm
Merck
FDA
Alzheimer's disease
Belsomra
insomnia
FDA clears Eisai’s insomnia drug Dayvigo
Pharmaforum
Mon, 12/30/19 - 11:01 am
FDA
Eisai
Dayvigo
insomnia
Merck
Belsomra
Merck Ready to Submit Belsomra to FDA for Alzheimer's Insomnia
BioSpace
Tue, 05/7/19 - 11:50 am
Merck
Belsomra
insomnia
Alzheimer's disease
Merck ramps up Belsomra marketing, hoping to wake up a sleepy insomnia market
Fierce Pharma Marketing
Mon, 06/15/15 - 09:51 am
Merck
insomnia
Belsomra
Merck's Quest To Revive The Market For Insomnia Drugs
Forbes
Thu, 06/4/15 - 08:20 pm
Merck
insomnia
Belsomra
Merck execs tout early yield from sleep drug Belsomra's launch
Fierce Pharma Marketing
Wed, 03/11/15 - 10:13 am
Merck
Belsomra
drug launches
insomnia
Merck finally rolls out sleep aid Belsomra after FDA roadblocks
Fierce Pharma
Wed, 02/4/15 - 08:34 am
Merck
Belsomra
insomnia
FDA
suvorexant
Most Popular News Headlines For Wednesday, August 13 2014
CP Wire
Thu, 08/14/14 - 10:11 am
Pfizer
Bristol-Myers Squibb
Eliquis
Belsomra
insomnia
Kyprolis
Aranesp
Amgen
InterMune
Sanofi
Roche
Most popular news headlines for Wednesday, August 13 2014
Thu, 08/14/14 - 10:09 am
Pfizer
Bristol-Myers Squibb
Eliquis
Belsomra
insomnia
Kyprolis
Aranesp
Amgen
InterMune
Sanofi
Roche
Merck Wins U.S. Approval of New Type of Sleeping Pill
Bloomberg
Wed, 08/13/14 - 04:42 pm
insomnia
Merck
FDA
Belsomra